Lifecore Biomedical
LFCR
LFCR
74 hedge funds and large institutions have $358M invested in Lifecore Biomedical in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
9.23% less ownership
Funds ownership: 74.74% → 65.51% (-9.2%)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
64% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 28
Holders
74
Holding in Top 10
5
Calls
$5.8M
Puts
$4.32M
Top Buyers
| 1 | +$84M | |
| 2 | +$3.63M | |
| 3 | +$2.65M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.23M |
| 5 |
Jane Street
New York
|
+$918K |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$3.58M | |
| 3 | -$2.56M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.99M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$1.89M |